Our fruit fly biotechnology
Fly by design
Our biomanufacturing platform, the EntoEngine™, uses the common fruit fly (Drosophila melanogaster) as its protein expression system.
Building on a century of genetics research, Future Fields is the first in the world to harness fruit flies for commercial recombinant protein production.
✓ Affordable development and production of proteins
✓ Unbeatable capacity due to scalable, bioreactor-free system
✓ Flexibility of protein development due to whole insect system
✓ Simple bioprocessing with serum-free output
Enabling great science
"Future Fields is a shining example of what is incredible about the innovation driving the bioeconomy. Using fruit flies as ‘factories’ for recombinant proteins is an ingenious approach to bringing more scalable and sustainable solutions to biomanufacturing."
- Dr. John Cumbers, founder and CEO of SynBioBeta
Our EntoEngine™ in action
Your next ethical purchase
Our fly-based growth factors earned the ACT Label in 2023 and are made in Green-certified lab
The data is in
Recombinant human FGF2 made by Future Fields' EntoEngine™ shows high performance
Support non-profits with us
1% of your purchase of fly-based proteins and services goes towards environmental causes
Flying around the world
How we deploy the EntoEngine™ to make your proteins
Click through this 10-slide overview to learn how we produce recombinant proteins with our whole-insect system.
We invest in the quality of our proteins. Our robust quality department and positive quality culture is supported by a Quality management system built on pharma-compliant software.
For custom protein solutions, we can accommodate quality standards that range from research use only to pre-clinical needs.
Acting on the climate crisis is one of Future Fields' core values. Creating sustainable biomolecules for life sciences is one way we are combating climate change.